Several biomarker tests have been available for over a decade, with extensive research backing their effectiveness. Yet, many ...

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

“We are thrilled to be the first company to evaluate multiple digital clinical biomarker endpoints in an ALS therapeutic trial to gauge short-term disease progression across key functional ...

A new study has shown that specific blood biomarkers could predict the onset of dementia, up to ten years before an actual ...

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

In a small study, lactotransferrin (LTF) was identified as a potentially important biomarker in extensive-stage small cell ...

Looking to the future of biomarker research, Dr. Irene De Biase, professor of clinical pathology at the University of Utah, expects to see an exponential growth in studies that use omic approaches to ...

In a study co-led by the University of Maryland School of Medicine (UMSOM), researchers have identified a “master regulator” ...

Dementia affects millions of people worldwide, causing a serious impact on the economy and the healthcare system. Alzheimer’s ...

There are a number of reasons why patients with cancer are encouraged to enroll in clinical trials, Dr. Michael J. Pishvaian ...